The biosimilars journey: current status and ongoing challenges
Biosimilar products are already approved and marketed in several countries. The Food and Drug Administration has approved ten different biosimilars, and the European Medicines Agency has approved 40. Even though this scenario has provided important experience with biosimilar products, there are stil...
Saved in:
Main Authors: | Igor Age Kos (Author), Valderílio Feijó Azevedo (Author), Daniel Egg Neto (Author), Sérgio Cândido Kowalski (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metformin: Ongoing Journey with Superdrug Revolution
by: Amr Ahmed EL-Arabey, et al.
Published: (2019) -
Biosimilars: Current regulatory perspective and challenges
by: Diwakar Jha, et al.
Published: (2013) -
Biosimilars in India; current status and future perspectives
by: Bikash R Meher, et al.
Published: (2019) -
Acceptance rate of clinical pharmacists' recommendations-an ongoing journey for integration
by: Orit Peled, et al.
Published: (2023) -
Risk factors and predictors of psoriatic arthritis in patients with psoriasis Fatores de risco e preditivos do desenvolvimento de artrite psoriásica em pacientes portadores de psoríase
by: Valderilio Feijó Azevedo, et al.
Published: (2013)